Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

TP53 Positively Regulates Cell Death through TRAILR2 (DR5) but Negatively through TRAILR1 (DR4) In Myeloma Cells

Sylvanie Surget, PhD, in, training, Patricia Gomez-Bougie, David Chiron, PhD, in, training, Robin Humphreys, PhD, Philippe Moreau, Steven Le Gouill, Jean-Luc Harousseau, Regis Bataille, MD, PhD, Martine Amiot, Catherine Pellat-Deceunynck, PhD

Blood (2010) 116 (21): 136.

https://doi.org/10.1182/blood.V116.21.136.136

Published: 2010

Journal Articles

High Bcl-2/Mcl-1 Gene Expression Ratio Identifies Molecular Sub-Groups of Multiple Myeloma Patients Extremely Sensitive to ABT-737

Linda Bodet, Catherine Pellat-Deceunynck, PhD, Patricia Gomez-Bougie, PhD, Christelle Dousset, Cyrille Touzeau, Steven Le Gouill, MD, PhD, Hervé Avet-Loiseau, MD, PhD, Regis Bataille, MD, PhD, Martine Amiot, PhD

Blood (2010) 116 (21): 4061.

https://doi.org/10.1182/blood.V116.21.4061.4061

Published: 2010

Journal Articles

Myeloma Cell Self-Renewal Depends on JAG2 Expression and Is Mediated by IGF1 or SCF Loop

David Chiron, PhD, in, training, Sophie Maiga, Géraldine Descamps, Severine Marionneau, Thilbaud Ouiller, Jerome Moreaux, Bernard Klein, PhD, MD, Philippe Moreau, Jean-Luc Harousseau, Regis Bataille, MD, PhD, Martine Amiot, Catherine Pellat-Deceunynck, PhD

Blood (2010) 116 (21): 127.

https://doi.org/10.1182/blood.V116.21.127.127

Published: 2010

Journal Articles

Molecular Prognosis in Multiple Myeloma: The IFM Experience.

Olivier Decaux, MD, Florence Magrangeas, PhD, Laurence Lode, PharmD, Catherine Charbonnel, Wilfried Gouraud, Philippe Moreau, MD, Jean-Luc Harousseau, MD, Michel Attal, MD, Regis Bataille, MD, PhD, Loic Campion, MD, Herve Avet Loiseau, MD, PhD, Stephane Minvielle, PhD

Blood (2006) 108 (11): 3491.

https://doi.org/10.1182/blood.V108.11.3491.3491

Published: 2006

Journal Articles

The Pan-Bcl-2 Inhibitor GX15-O70 Induces Apoptosis in Human Myeloma Cells by Noxa Induction and Strongly Enhances Melphalan, Bortezomib or TRAIL-R1 Antibody Apoptotic Effect.

Patricia Gomez-Bougie, MD, PhD, Sophie Maïga, BSc, Catherine Pellat-Deceunynck, PhD, Sandrine Jouan, MSc, Regis Bataille, MD PhD, Martine Amiot, PhD

Blood (2006) 108 (11): 3476.

https://doi.org/10.1182/blood.V108.11.3476.3476

Published: 2006

Journal Articles

A Humanized Anti-IGF-1R Monoclonal Antibody (AVE1642) Synergizes with Bortezomib To Induce Apoptosis in CD45neg Myeloma Cells.

Geraldine Descamps, PhD, Soraya Wuilleme-Toumi, MD, Patricia Gomez-Bougie, MD, PhD, Corinne Venot, PhD, Friedhelm Bladt Bladt, PhD, Regis Bataille, MD, PhD, Martine Amiot, PhD

Blood (2006) 108 (11): 845.

https://doi.org/10.1182/blood.V108.11.845.845

Published: 2006

Journal Articles

The Critical Role of Survivin in the Survival and Proliferation of Human Myeloma Cells.

Mathilde Romagnoli, Regis Bataille, MD, PhD, Sophie Barillé-Nion, Pharm, PhD

Blood (2005) 106 (11): 110.

https://doi.org/10.1182/blood.V106.11.110.110

Published: 2005

Journal Articles

TRAILR Triggering by Human Antibodies Induces Apoptosis through an Early Cleavage of Mcl-1 and Caspase 3 in Myeloma Cells.

Catherine Pellat-Deceunynck, PhD, Patricia Gomez-Bougie, MD, Sylvanne Daniels, Alexandrine Geffroy-Luseau, Regis Bataille, MD, PhD, Martine Amiot, PhD

Blood (2005) 106 (11): 3397.

https://doi.org/10.1182/blood.V106.11.3397.3397

Published: 2005

Journal Articles

Identification and Hierarchy of Clonogenic Factors for Human Myeloma Cells: IL-6 for CD45+ Versus IL-6 and Growth Factors for CD45-.

Martine Amiot, PhD, Regis Bataille, MD, PhD, Madeleine Collette, Geraldine Descamps, Catherine Pellat-deceunynck, PhD

Blood (2005) 106 (11): 3407.

https://doi.org/10.1182/blood.V106.11.3407.3407

Published: 2005

Journal Articles

HLA-Cw6 Alloreactive CTL Recognizing HLA-CW6+ Myeloma Cells but Not Non-Myeloma HLA-Cw6+ Cells Are Peptide Dependent.

Alexandrine Geffroy, Agnes Moreau-Aubry, PhD, Regis Bataille, MD PhD, Catherine Pellat-Deceunynck, PhD

Blood (2004) 104 (11): 2474.

https://doi.org/10.1182/blood.V104.11.2474.2474

Published: 2004

Journal Articles

Mcl-1 Is Overexpressed in Multiple Myeloma and Correlates with Disease Severity.

Soraya Wuilleme-Toumi, MD, Nelly Robillard, PhD, Patricia Gomez-Bougie, MD, Philippe Moreau, MD, Steven Le Gouill, MD, Herve Avet-Loiseau, MD, PhD, Jean-Luc Harousseau, MD, Martine Amiot, PhD, Regis Bataille, MD, PhD

Blood (2004) 104 (11): 1419.

https://doi.org/10.1182/blood.V104.11.1419.1419

Published: 2004

Journal Articles

The Coexpression of CD11a and CD45bright Is the Hallmark of Proliferating Myeloma Cells.

Catherine Pellat-Deceunynck, PhD, Nelly Robillard, PhD, Regis Bataille, MD, PhD

Blood (2004) 104 (11): 3347.

https://doi.org/10.1182/blood.V104.11.3347.3347

Published: 2004

Journal Articles

Mcl-1 Sequesters Pro-Apoptotic BH3-Only Bim To Inhibit Its Collaboration with Bax in Myeloma Cells.

Patricia Gomez-Bougie, MD, Monique Clement, PhD, Philipe Juin, PhD, Regis Bataille, MD, Martine Amiot, PhD

Blood (2004) 104 (11): 789.

https://doi.org/10.1182/blood.V104.11.789.789

Published: 2004

NARROW

TP53 Positively Regulates Cell Death through TRAILR2 (DR5) but Negatively through TRAILR1 (DR4) In Myeloma Cells

High Bcl-2/Mcl-1 Gene Expression Ratio Identifies Molecular Sub-Groups of Multiple Myeloma Patients Extremely Sensitive to ABT-737

Myeloma Cell Self-Renewal Depends on JAG2 Expression and Is Mediated by IGF1 or SCF Loop

Molecular Prognosis in Multiple Myeloma: The IFM Experience.

The Pan-Bcl-2 Inhibitor GX15-O70 Induces Apoptosis in Human Myeloma Cells by Noxa Induction and Strongly Enhances Melphalan, Bortezomib or TRAIL-R1 Antibody Apoptotic Effect.

A Humanized Anti-IGF-1R Monoclonal Antibody (AVE1642) Synergizes with Bortezomib To Induce Apoptosis in CD45neg Myeloma Cells.

The Critical Role of Survivin in the Survival and Proliferation of Human Myeloma Cells.

TRAILR Triggering by Human Antibodies Induces Apoptosis through an Early Cleavage of Mcl-1 and Caspase 3 in Myeloma Cells.

Identification and Hierarchy of Clonogenic Factors for Human Myeloma Cells: IL-6 for CD45+ Versus IL-6 and Growth Factors for CD45-.

HLA-Cw6 Alloreactive CTL Recognizing HLA-CW6+ Myeloma Cells but Not Non-Myeloma HLA-Cw6+ Cells Are Peptide Dependent.

Mcl-1 Is Overexpressed in Multiple Myeloma and Correlates with Disease Severity.

The Coexpression of CD11a and CD45bright Is the Hallmark of Proliferating Myeloma Cells.

Mcl-1 Sequesters Pro-Apoptotic BH3-Only Bim To Inhibit Its Collaboration with Bax in Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only